Please enable Javascript
Heart Failure Congress 2025
Advertisement
Delayed Diagnosis Common in ATTR-CM, Study Finds
Rob Dillard
Heart Failure
|
June 12, 2025
Patients experienced a median 57.6-month delay from first symptoms to ATTR-CM diagnosis, study finds.
Read More
Acoramidis Cuts AFib Hospitalizations in ATTR Amyloidosis
CardioNerds
Heart Failure
|
June 12, 2025
MITT and safety data show acoramidis significantly lowers AFib-related events in transthyretin cardiac amyloidosis.
View More
Acoramidis Reduces Atrial Fibrillation Burden in ATTR-CM: ESC 2025 Insights
CardioNerds
Heart Failure Congress 2025
|
June 5, 2025
ESC 2025: Acoramidis may reduce AF/flutter burden in ATTR-CM, per new ATTRibute-CM trial analysis discussed by CardioNerds.
View More
Pulmonary Regurgitation Predicts Heart Failure, Short-Term Death
Rob Dillard
Heart Failure Congress 2025
|
June 5, 2025
PVR severity is linked to higher short-term mortality in HFrEF, highlighting its role in risk stratification.
Read More
Study Finds Checklist Boosts Detection of ATTR-CM
Rob Dillard
Heart Failure Congress 2025
|
May 20, 2025
Checklist use for ATTR-CM "red flags" boosted diagnosis rates up to 10x in heart failure patients, study finds.
Read More
Youth Heart Failure Surges: Urgent Global Action Needed
Rob Dillard
Heart Failure Congress 2025
|
May 20, 2025
Heart failure affects over 640,000 kids and teens globally—urgent prevention and care policies are needed, study finds.
Read More
Waist-to-Height Ratio Tops BMI in Predicting Heart Failure
Rob Dillard
Heart Failure Congress 2025
|
May 20, 2025
Waist-to-height ratio may better predict heart failure risk than BMI, new Heart Failure 2025 study finds.
Read More
Acoramidis Rapidly Boosts sTTR in ATTR-CM
Rob Dillard
Heart Failure Congress 2025
|
May 20, 2025
Acoramidis rapidly boosts serum TTR levels in ATTR-CM patients, with effects sustained through 30 months, study shows.
Read More
Advertisement
Advertisement